Drug Trial Radar · NCT07546760
A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
28
Planned (sponsor's estimate)
Start
Mar 20, 2026
Primary completion
Feb 4, 2027
Study completion Feb 4, 2027
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Apr 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to examine the safety and tolerability of AZD6234 and AZD9550 in participants with hepatic impairment and participants with normal hepatic function.
Conditions
- Hepatic Impairment
Interventions
AZD6234Drug
Single subcutaneous dose of AZD6234 in participants from all groups
AZD9550Drug
Single subcutaneous dose of AZD9550 in participants from all groups
Primary outcomes
What the sponsor says the trial is designed to measure.
- PK parameters AUCinfTime frame: Day 0 through Day 56
- PK parameters AUClastTime frame: Day 0 through Day 56
- PK parameters CmaxTime frame: Day 0 through Day 56
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Chandler, Arizona · Recruiting
Research Site
Rialto, California · Terminated
Research Site
Miami Lakes, Florida · Recruiting
Research Site
San Antonio, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.